Orum Therapeutics, Inc. (KOSDAQ:475830)

Orum Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	113,623	4,065	19,700	126,658	11,276
Short-Term Investments	10,006	128,537	99,099	-	-
Trading Asset Securities	128,277	-	-	-	809.55
Cash & Short-Term Investments	251,906	132,602	118,799	126,658	12,085
Cash Growth	69.32%	11.62%	-6.21%	948.05%	-
Accounts Receivable	-	0.56	2.48	0.6	-
Other Receivables	1,290	380.84	2,530	492.53	38.37
Receivables	1,290	381.4	2,532	493.14	38.37
Prepaid Expenses	2,150	715.19	966.55	254.5	460.26
Other Current Assets	769.59	674.09	212.88	41.83	72.42
Total Current Assets	256,116	134,372	122,510	127,448	12,656
Property, Plant & Equipment	31,583	31,014	30,610	32,370	5,184
Long-Term Investments	46.25	43.05	44.1	12.87	2,552
Long-Term Deferred Tax Assets	2,975	2,769	597.08	974.69	543.48
Other Long-Term Assets	1,272	1,126	74.48	977.7	346.91
Total Assets	291,993	169,325	153,836	161,783	21,283

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Accounts Payable	-	-	-	3.45	839.48
Accrued Expenses	3,182	4,056	2,079	5,138	4,932
Short-Term Debt	69,364	-	-	-	208.32
Current Portion of Leases	3,003	2,776	28,122	2,572	845.64
Current Income Taxes Payable	-	-	-	217.72	462.26
Other Current Liabilities	6,419	8,777	1,663	1,207	1,633
Total Current Liabilities	81,967	15,608	31,864	9,137	8,920
Long-Term Debt	-	-	-	-	937.44
Long-Term Leases	23,831	22,723	207.75	23,308	597.78
Other Long-Term Liabilities	117.48	105.47	0	138.26	136.6
Total Liabilities	105,989	38,437	32,071	32,583	10,592

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Common Stock	2,172	2,123	1,843	460	115
Additional Paid-In Capital	106,178	100,366	179,471	690	1,035
Retained Earnings	66,325	18,218	-69,813	-64,072	-132,290
Comprehensive Income & Other	11,329	10,181	10,263	6,743	3,678
Total Common Equity	186,004	130,888	121,765	-56,180	-127,461
Shareholders' Equity	186,004	130,888	121,765	129,200	10,691
Total Liabilities & Equity	291,993	169,325	153,836	161,783	21,283

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Total Debt	96,198	25,498	28,330	25,879	2,589
Net Cash (Debt)	155,709	107,103	90,469	100,779	9,496
Net Cash Growth	25.32%	18.39%	-10.23%	961.28%	-
Net Cash Per Share	7313.73	5146.28	6682.58	6693.64	2064.33
Filing Date Shares Outstanding	21.57	21.23	18.43	4.6	1.15
Total Common Shares Outstanding	21.57	21.23	18.43	4.6	1.15
Working Capital	174,149	118,764	90,647	118,310	3,736
Book Value Per Share	8621.68	6164.55	6607.19	-12212.99	-110835.99
Tangible Book Value	186,004	130,888	121,765	-56,180	-127,461
Tangible Book Value Per Share	8621.68	6164.55	6607.19	-12212.99	-110835.99
Land	-	-	-	-	1,591
Machinery	5,929	5,388	1,497	1,396	1,406
Construction In Progress	-	250	36	-	445.16

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error